XWEL Stock Analysis: Buy, Sell, or Hold?
XWEL - XWELL, Inc. Common Stock
$1.11
-0.09 (-7.50%)
▼
5d:
-19.57%
30d:
-25.5%
90d:
+79.61%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 21, 2026
20d
Get Alerted When XWEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XWEL is down 19.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: XWEL is down 19.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: XWEL is currently trading at $1.11, which is considered fair relative to its 30-day fair value range of $0.85 to $1.59.
Technical Outlook: Technically, XWEL is in a uptrend. The price is currently testing key support at $1.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+530.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XWEL is in a uptrend. The price is currently testing key support at $1.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+530.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.85 -
$1.59
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 530.6% below Wall St target ($7.00)
- WARNING: Recommendation downgraded due to -19.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.85 -
$1.59
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.44
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Wall Street Target
$7.00
(+530.6%)
Revenue Growth (YoY)
-12.8%
Profit Margin
-51.8%
Share & Embed Analysis
Last updated: March 30, 2026 8:54 PM ET
Data refreshes hourly during market hours. Next update: 9:54 PM
Data refreshes hourly during market hours. Next update: 9:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XWEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 61 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 54 HOLD |